Sparsentan is a pharmaceutical raw material that functions as a dual endothelin and angiotensin receptor antagonist. It is studied for its potential role in conditions such as primary immunoglobulin A nephropathy and focal segmental glomerulosclerosis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Sparsentan?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
4'-((2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-N-(4,5-dimethylisoxazol-3-yl)-2'-(ethoxymethyl)-N-(methoxymethyl)-[1,1'-biphenyl]-2-sulfonamide
pharmaceutical intermediate
Isoquinolin-3-amine
pharmaceutical raw material
Lirafugratinib
pharmaceutical raw material
Clindamycin palmitate hydrochloride
pharmaceutical raw material
Alovudine
pharmaceutical raw material
The international HS code for Sparsentan (CAS 254740-64-2) is 2935.90.
2935.90
2935 90 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-[4-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2-(ethoxymethyl)phenyl]-N-(4,5-dimethyl-1,2-oxazol-3-yl)benzenesulfonamide
WRFHGDPIDHPWIQ-UHFFFAOYSA-N
CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC(=C(C=C3)C4=CC=CC=C4S(=O)(=O)NC5=NOC(=C5C)C)COCC
Sourcing Sparsentan?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.